1.
Product Overview
2.
Research Methodology
3.
Executive Summary
4.
Impact of COVID-19 on Global Deep Brain Stimulation
Devices Market
5.
Voice of Customer
5.1. Common Neurological
Disorders in which Deep Brain Stimulation Devices are used
5.2. Preference of Deep
Brain Stimulation Devices, By Product Type
5.3. Preference of Deep
Brain Stimulation Devices, By Type
5.4. Brand Awareness
6. Global Deep Brain
Stimulation Devices Market Outlook
6.1.
Market Size & Forecast
6.1.1. By Value
6.2.
Market Share & Forecast
6.2.1. By Product Type (Dual-Channel Deep Brain
Stimulator, Single-Channel Deep Brain Stimulator,)
6.2.2. By Type (Rechargeable and Non-Rechargeable)
6.2.3. By Application (Parkinson's Disease, Epilepsy,
Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others)
6.2.4. By End User (Hospitals
& Clinics, Ambulatory Surgical Centers, Neurological Clinics, Others)
6.2.5. By Company (2021)
6.2.6.
By Region
6.3.
Market Map
7. North America Deep
Brain Stimulation Devices Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value
7.2.
Market Share & Forecast
7.2.1. By Product Type (Dual-Channel Deep Brain
Stimulator, Single-Channel Deep Brain Stimulator,)
7.2.2. By Type (Rechargeable and Non-Rechargeable)
7.2.3. By Application (Parkinson's Disease, Epilepsy,
Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others)
7.2.4. By End User (Hospitals
& Clinics, Ambulatory Surgical Centers, Neurological Clinics, Others)
7.2.5. By Country
7.3.
North America: Country Analysis
7.3.1. United States Deep
Brain Stimulation Devices Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Product Type
7.3.1.2.2.
By Application
7.3.1.2.3.
By End User
7.3.2. Mexico Deep Brain
Stimulation Devices Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Product Type
7.3.2.2.2.
By Application
7.3.2.2.3.
By End User
7.3.3. Canada Deep Brain
Stimulation Devices Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Product Type
7.3.3.2.2.
By Application
7.3.3.2.3.
By End User
8. Europe Deep Brain
Stimulation Devices Market Outlook
8.1.
Market Size & Forecast
8.1.1. By Value
8.2.
Market Share & Forecast
8.2.1. By Product Type (Dual-Channel Deep Brain Stimulator,
Single-Channel Deep Brain Stimulator,)
8.2.2. By Type (Rechargeable and Non-Rechargeable)
8.2.3. By Application (Parkinson's Disease, Epilepsy,
Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others)
8.2.4. By End User (Hospitals
& Clinics, Ambulatory Surgical Centers, Neurological Clinics, Others)
8.2.5. By Country
8.3.
Europe: Country Analysis
8.3.1. Germany Deep Brain
Stimulation Devices Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Product Type
8.3.1.2.2.
By Application
8.3.1.2.3.
By End User
8.3.2. United Kingdom Deep
Brain Stimulation Devices Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Product Type
8.3.2.2.2.
By Application
8.3.2.2.3.
By End User
8.3.3. France Deep Brain
Stimulation Devices Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Product Type
8.3.3.2.2.
By Application
8.3.3.2.3.
By End User
8.3.4. Italy Deep Brain
Stimulation Devices Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Product Type
8.3.4.2.2.
By Application
8.3.4.2.3.
By End User
8.3.5. Spain Deep Brain
Stimulation Devices Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Product Type
8.3.5.2.2.
By Application
8.3.5.2.3.
By End User
9. Asia Pacific Deep
Brain Stimulation Devices Market Outlook
9.1.
Market Size & Forecast
9.1.1. By Value
9.2.
Market Share & Forecast
9.2.1. By Product Type (Dual-Channel Deep Brain
Stimulator, Single-Channel Deep Brain Stimulator,)
9.2.2. By Type (Rechargeable and Non-Rechargeable)
9.2.3. By Application (Parkinson's Disease, Epilepsy,
Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others)
9.2.4. By End User (Hospitals
& Clinics, Ambulatory Surgical Centers, Neurological Clinics, Others)
9.2.5. By Country
9.3.
Asia Pacific: Country Analysis
9.3.1. China Deep Brain
Stimulation Devices Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Product Type
9.3.1.2.2.
By Application
9.3.1.2.3.
By End User
9.3.2. India Deep Brain
Stimulation Devices Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Product Type
9.3.2.2.2.
By Application
9.3.2.2.3.
By End User
9.3.3. Japan Deep Brain
Stimulation Devices Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Product Type
9.3.3.2.2.
By Application
9.3.3.2.3.
By End User
9.3.4. South Korea Deep
Brain Stimulation Devices Market Outlook
9.3.4.1.
Market Size & Forecast
9.3.4.1.1.
By Value
9.3.4.2.
Market Share & Forecast
9.3.4.2.1.
By Product Type
9.3.4.2.2.
By Application
9.3.4.2.3.
By End User
9.3.5. Australia Deep Brain
Stimulation Devices Market Outlook
9.3.5.1.
Market Size & Forecast
9.3.5.1.1.
By Value
9.3.5.2.
Market Share & Forecast
9.3.5.2.1.
By Product Type
9.3.5.2.2.
By Application
9.3.5.2.3.
By End User
10. South America Deep
Brain Stimulation Devices Market Outlook
10.1.
Market Size & Forecast
10.1.1. By Value
10.2.
Market Share & Forecast
10.2.1. By Product Type (Dual-Channel Deep Brain
Stimulator, Single-Channel Deep Brain Stimulator,)
10.2.2. By Type (Rechargeable and Non-Rechargeable)
10.2.3. By Application (Parkinson's Disease, Epilepsy,
Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others)
10.2.4. By End User (Hospitals
& Clinics, Ambulatory Surgical Centers, Neurological Clinics, Others)
10.2.5. By Country
10.3.
South America: Country Analysis
10.3.1. Brazil Deep Brain
Stimulation Devices Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1.
By Product Type
10.3.1.2.2.
By Application
10.3.1.2.3.
By End User
10.3.2. Argentina Deep Brain
Stimulation Devices Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1.
By Product Type
10.3.2.2.2.
By Application
10.3.2.2.3.
By End User
10.3.3. Colombia Deep Brain Stimulation
Devices Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1.
By Product Type
10.3.3.2.2.
By Application
10.3.3.2.3.
By End User
11. Middle East and
Africa Deep Brain Stimulation Devices Market Outlook
11.1.
Market Size & Forecast
11.1.1. By Value
11.2.
Market Share & Forecast
11.2.1. By Product Type (Dual-Channel Deep Brain
Stimulator, Single-Channel Deep Brain Stimulator,)
11.2.2. By Type (Rechargeable and Non-Rechargeable)
11.2.3. By Application (Parkinson's Disease, Epilepsy,
Essential Tremor, Dystonia, Obsessive Compulsive Disorder, Others)
11.2.4. By End User (Hospitals
& Clinics, Ambulatory Surgical Centers, Neurological Clinics, Others)
11.2.5. By Country
11.3.
Middle East and Africa: Country Analysis
11.3.1. South Africa Deep
Brain Stimulation Devices Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1.
By Product Type
11.3.1.2.2.
By Application
11.3.1.2.3.
By End User
11.3.2. Saudi Arabia Deep
Brain Stimulation Devices Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1.
By Product Type
11.3.2.2.2.
By Application
11.3.2.2.3.
By End User
11.3.3. UAE Deep Brain Stimulation
Devices Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1.
By Product Type
11.3.3.2.2.
By Application
11.3.3.2.3.
By End User
11.3.4. Kuwait Deep Brain
Stimulation Devices Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1.
By Product Type
11.3.4.2.2.
By Application
11.3.4.2.3.
By End User
12.
Market Dynamics
12.1.
Drivers
12.2.
Challenges
13.
Market Trends and Developments
14. Competitive Landscape
14.2.1. Medtronic PLC
14.2.2. Abbott Laboratories (St. Jude Medical)
14.2.3. Boston Scientific Corporation
14.2.4. Beijing PINS Medical Co. Ltd
14.2.5. NeuroSigma, Inc.
14.2.6. Functional Neuromodulation Ltd
14.2.7. Fisher Wallace
14.2.8. NeuroPace Inc.
14.2.9. Renishaw PLC
14.2.10. ALEVA NEUROTHERAPEUTICS SA
14.2.11. LivaNova PLC
14.2.12. SceneRay Corporation
14.2.13. Nevro Corporation
14.2.14. Neuronetics Inc.
15. Strategic Recommendations